## Core Concept
The patient's symptoms suggest an acute onset of a systemic condition characterized by rash, mucocutaneous lesions, and systemic symptoms like fever. The initial presentation could be indicative of **Stevens-Johnson Syndrome (SJS)**, a severe skin and mucous membrane disorder, often triggered by medications or infections. The administration of oral penicillin for presumed streptococcal pharyngitis might have been a triggering factor.

## Why the Correct Answer is Right
The condition described aligns with Stevens-Johnson Syndrome, a medical emergency. The treatment of SJS primarily involves supportive care, including fluid and electrolyte management, pain control, and prevention of infection. Certain medications are crucial in the management, while others can exacerbate the condition.

## Why Each Wrong Option is Incorrect
- **Option A:** Not specified, but assuming it's a treatment option for SJS or similar conditions.
- **Option B:** Not specified, but potentially a treatment for the condition or its symptoms.
- **Option C:** Not specified, but could be relevant to managing SJS or related conditions.
- **Option D:** This option is stated as the correct answer but without specifics, we can infer that it's not suitable for SJS treatment.

## Why Each Distractor is Wrong (Assuming D is Correct)
- **Option A:** Assuming A is a corticosteroid or another anti-inflammatory, these might be used cautiously in some cases for their anti-inflammatory effects but are generally not recommended due to concerns about impairing the immune response.
- **Option B:** If B represents a standard treatment approach like supportive care or specific therapies for SJS (e.g., intravenous immunoglobulin), it would be appropriate.
- **Option C:** If C is another treatment modality (e.g., antibiotics for secondary infections), it could be relevant.

## Clinical Pearl / High-Yield Fact
In managing a condition like Stevens-Johnson Syndrome, it's critical to **discontinue the offending agent** immediately. Supportive care is the mainstay of treatment. The use of **intravenous immunoglobulin (IVIG)** and **tocilizumab** has been explored as potential therapeutic options. A key pearl is to avoid using **steroids** routinely due to the potential to worsen outcomes, though their use is controversial and context-dependent.

## Correct Answer: D.